Search results for "Blood Transfusion"

showing 10 items of 100 documents

Red blood cell transfusion in perioperative pediatric anesthesia: a survey of current practice in Germany.

2018

BACKGROUND Little is known about the current practice of the perioperative transfusion of red blood cells (RBCs) in pediatric patients. This study was performed to evaluate the practice of RBC transfusion in German pediatric anesthesia. STUDY DESIGN AND METHODS An online survey was conducted among members of the German Society of Anesthesiology and Intensive Care. Participants were asked to indicate the hemoglobin (Hb) thresholds for starting RBC transfusion in six cases of different bleeding situations in pediatric anesthesia. Demographics of participants, general knowledge, and application of transfusion rules and guidelines were assessed. RESULTS We included 1207 of 1396 returned questio…

MalePediatricsmedicine.medical_specialtyBlood transfusionAdolescentCritical Caremedicine.medical_treatmentImmunology030204 cardiovascular system & hematology03 medical and health sciencesHemoglobins0302 clinical medicine030202 anesthesiologyInterquartile rangeIntensive careAnesthesiologyGermanySurveys and QuestionnairesImmunology and AllergyMedicineHumansAnesthesiaChildPerioperative Periodbusiness.industryInfant NewbornInfantHematologyGuidelinePerioperativeCurrent practiceFemalePediatric anesthesiabusinessErythrocyte TransfusionTransfusionREFERENCES
researchProduct

Recombinant erythropoietin vs. blood transfusion care in infants with hereditary spherocytosis: a retrospective cohort study of A.I.E.O.P. patients (…

2017

MalePediatricsmedicine.medical_specialtyBlood transfusionReticulocytesAnemiamedicine.medical_treatmentSpherocytosisSpherocytosisMEDLINEErythrocyte Count; Erythropoietin; Female; Follow-Up Studies; Hemoglobins; Humans; Infant; Infant Newborn; Italy; Male; Recombinant Proteins; Reticulocytes; Retrospective Studies; Spherocytosis Hereditary; Blood Transfusion; HematologyHereditary spherocytosis03 medical and health sciencesHemoglobins0302 clinical medicinemedicineHumansBlood TransfusionRecombinant erythropoietinErythropoietinErythrocyte Count; Erythropoietin; Female; Follow-Up Studies; Hemoglobins; Humans; Infant; Infant Newborn; Italy; Male; Recombinant Proteins; Reticulocytes; Retrospective Studies; Spherocytosis Hereditary; Blood TransfusionRetrospective Studiesbusiness.industryInfantRetrospective cohort studyHematologymedicine.diseaseNewbornRecombinant ProteinsSurgeryHereditaryItalyErythropoietin030220 oncology & carcinogenesisErythrocyte Count030211 gastroenterology & hepatologyFemalebusinessmedicine.drugFollow-Up Studies
researchProduct

Improving survival with deferiprone treatment in patients with thalassemia major: A prospective multicenter randomised clinical trial under the auspi…

2009

The prognosis for thalassemia major has dramatically improved in the last two decades. However, many transfusion-dependent patients continue to develop progressive accumulation of iron. This can lead to tissue damage and eventually death, particularly from cardiac disease. Previous studies that investigated iron chelation treatments, including retrospective and prospective non-randomised clinical trials, suggested that mortality, due mainly to cardiac damage, was reduced or completely absent in patients treated with deferiprone (DFP) alone or a combined deferiprone-deferoxamine (DFP-DFO) chelation treatment. However, no survival analysis has been reported for a long-term randomised control …

MaleThalassemiaKaplan-Meier Estimatelaw.inventionchemistry.chemical_compoundRandomized controlled triallawCause of DeathNeoplasmsDeferiproneProspective StudiesChildCause of deathHazard ratioHematologyMiddle AgedCombined Modality TherapySurvival RateThalassemia survival chelation treatment trial thalassemia majorCombinationSplenectomyMolecular MedicineDrug Therapy CombinationFemaleDeferiproneAdultmedicine.medical_specialtyAdolescentPyridonesDeferoxamineIron Chelating AgentsYoung AdultDrug TherapyInternal medicinemedicineHumansBlood TransfusionAdolescent; Adult; Blood Transfusion; Cause of Death; Chelation Therapy; Child; Combined Modality Therapy; Deferoxamine; Drug Therapy; Combination; Female; Heart Failure; Humans; Iron Chelating Agents; Kaplan-Meiers Estimate; Male; Middle Aged; Neoplasms; Proportional Hazards Models; Prospective Studies; Pyridones; Splenectomy; Survival Rate; Young Adult; beta-ThalassemiaMolecular BiologySurvival rateKaplan-Meiers EstimateSurvival analysisProportional Hazards ModelsHeart Failurebusiness.industryProportional hazards modelbeta-ThalassemiaCell Biologymedicine.diseaseChelation TherapySurgerychemistrybusiness
researchProduct

Blood Transfusion in Elderly Patients with Acute Myocardial Infarction: Data from the RICO Survey.

2017

Red blood cell transfusion benefit during acute myocardial infarction remains unclear in the elderly. We aimed to assess the transfusion impact on 1-year mortality in acute myocardial infarction patients aged ≥65 years, according to their age and hemoglobin nadir.We included 3316 consecutive patients with acute myocardial infarction aged ≥65 years from the "obseRvatoire des Infarctus de Côte d'Or" (RICO) survey. They were categorized according to their hemoglobin nadir (≤8,8 to ≤10, and10 g/dL) and age (80 or ≥80 years).A total of 1906 patients (57%) were 65-79 years old, and 1410 (43%) were aged ≥80 years, of whom 103 (5%) and 145 (10%) patients received red blood cell transfusion, respect…

Malemedicine.medical_specialtyBlood transfusionAnemiamedicine.medical_treatmentMyocardial Infarction030204 cardiovascular system & hematology03 medical and health sciencesHemoglobins0302 clinical medicineOlder patientsInternal medicinemedicineHumansIn patientBlood Transfusion030212 general & internal medicineMyocardial infarctionProspective StudiesAgedAged 80 and overbusiness.industryAnemiaGeneral Medicinemedicine.diseaseConfidence intervalSurgeryTreatment OutcomeFemaleHemoglobinFrancebusinessNadir (topography)The American journal of medicine
researchProduct

Effects of red blood cell transfusion on anemia-related symptoms in patients with cancer.

2009

The aim of this study was to assess the effects of red blood cell transfusion, and the subsequent increase in hemoglobin values, on anemia-related symptoms in a cohort of patients with cancer with different survival times. A red blood cell transfusion was recommended to a consecutive sample of patients with hemoglobin levels of 8 +/- 0.5 g/dL. The number of units to be ordered was decided according the hemoglobin values with a mean target of increasing the hemoglobin values by approximately 2 g/dL. Hemoglobin values, anemia-related signs and symptoms, including well-being, fatigue, and dyspnea, were recorded at admission (T0), 1 day after the last transfusion (T1), and 15 days afterward (T2…

Malemedicine.medical_specialtyBlood transfusionAnemiamedicine.medical_treatmentRed Blood Cell TransfusionSettore MED/41 - AnestesiologiaNeoplasmsOutcome Assessment Health CaremedicineHumansIn patientGeneral NursingAgedcritical care in cancer patientsbusiness.industryCancerAnemiaGeneral MedicineMiddle Agedmedicine.diseaseConfidence intervalSurgeryAnesthesiology and Pain MedicineAnesthesiaCohortFemaleHemoglobinbusinessErythrocyte TransfusionJournal of palliative medicine
researchProduct

Elevation of plasma viscosity induces sustained NO-mediated dilation in the hamster cremaster microcirculation in vivo

1997

We studied whether a flow-independent increase of luminal wall shear stress (WSS) could dilate hamster arterioles in vivo and which endothelial mediators are potentially involved. To this end the plasma viscosity was elevated by exchanging blood for dextran-erythrocyte solution thereby augmenting WSS. Diameters of small and large arterioles as well as red blood cell velocities were measured before and after exchange of blood for solutions of identical haematocrit containing either high- (HMWD) or low-molecular weight dextran (LMWD). The potential role of endothelial autacoids was investigated by local application of the NO-synthase inhibitor NG-nitro-L-arginine (L-NNA), the inhibitor of cyc…

Malemedicine.medical_specialtyEndotheliumPhysiologyClinical BiochemistryPlasma SubstitutesHamsterGenitalia MaleNitric OxideMicrocirculationPlasmachemistry.chemical_compoundIn vivoCricetinaePhysiology (medical)Internal medicinePotassium Channel BlockersmedicineAnimalsBlood TransfusionCyclooxygenase InhibitorsMesocricetusMusclesDextransAnatomyBlood ViscosityMolecular WeightVasodilationArteriolesRed blood cellDextranmedicine.anatomical_structureEndocrinologychemistrycardiovascular systemDilation (morphology)Stress MechanicalNitric Oxide SynthaseErythrocyte TransfusionAutacoidcirculatory and respiratory physiologyPfl�gers Archiv European Journal of Physiology
researchProduct

Postoperative Costs Associated With Outcomes After Cardiac Surgery With Extracorporeal Circulation: Role of Antithrombin Levels

2012

Objective: To study the impact on postoperative costs of a patient's antithrombin levels associated with outcomes after cardiac surgery with extracorporeal circulation. Design: An analytic decision model was designed to estimate costs and clinical outcomes after cardiac surgery in a typical patient with low antithrombin levels (= 63.7%). The data used in the model were obtained from a literature review and subsequently validated by a panel of experts in cardiothoracic anesthesiology. Setting: Multi-institutional (14 Spanish hospitals). Participants: Consultant anesthesiologists. Measurements and Main Results: A sensitivity analysis of extreme scenarios was carried out to assess the impact o…

Malemedicine.medical_specialtyExtracorporeal Circulationextracorporeal circulationCardiotonic AgentsMyocardial InfarctionAntithrombinsDrug Costslaw.inventionPostoperative ComplicationsDrug TherapylawSurveys and QuestionnairesThromboembolismAtrial FibrillationmedicineCardiopulmonary bypassHumansBlood TransfusionCardiac Surgical ProceduresCardiothoracic anesthesiologyAverage costAgedPostoperative Carebusiness.industryAntithrombinExtracorporeal circulationDecision TreesAntithrombin ActivityLength of StayMiddle AgedSurgeryCardiac surgeryStrokeIntensive Care UnitsantithrombinAnesthesiology and Pain MedicineTreatment OutcomeSpainHealth Care SurveysEmergency medicineCosts and Cost AnalysisFemaleKidney DiseasesCardiology and Cardiovascular Medicinebusinesscardiopulmonary bypassHospital staymedicine.drug
researchProduct

Factors involved in gastrointestinal bleeding in advanced cancer patients followed at home

2003

Abstract There is a lack of information on the frequency of symptomatic gastrointestinal bleeding in patients with advanced cancer. This group of patients presents several risk factors for developing gastrointestinal bleeding. The aim of this multicenter longitudinal survey was to assess the frequency of gastrointestinal bleeding and possible factors implicated in advanced cancer patients followed at home. A consecutive sample of 439 patients who referred to home palliative care program entered the study. Age, gender, primary cancer and known metastases, possible associated pathologies, history of peptic disease, use of previous or actual nonsteroidal anti-inflammatory drugs (NSAIDs) and st…

Malemedicine.medical_specialtyGastrointestinal bleedingPalliative careBlood transfusionAnemiamedicine.medical_treatmentgastrointestinal bleedingSettore MED/42 - Igiene Generale E ApplicataGastroenterologyadvanced cancer patientGastrointestinal AgentsRisk FactorsMelenaNeoplasmsInternal medicinemedicineHumansLongitudinal StudiesProspective StudiesProspective cohort studybusiness.industryAnti-Inflammatory Agents Non-SteroidalPalliative CareCancermedicine.diseaseHome Care ServicesAdvanced cancerhome palliative careOncologyFemaleSteroidsmedicine.symptomGastrointestinal HemorrhagebusinessFollow-Up StudiesSupportive Care in Cancer
researchProduct

Minor hepatic resection using heat coagulative necrosis

2009

Intra- and postoperative bleeding represents an extremely serious and frequent complication of hepatic surgery. In this study, we evaluated the effectiveness of a radiofrequency (RF) device using heat to cause coagulative necrosis of the hepatic parenchyma to control hemostasis in minor hepatic resection. Between December 2005 and November 2007, a study was conducted of 21 patients undergoing 22 hepatic resections with the RF-assisted technique. Sixteen of these were affected by hepatocellular carcinoma and five had liver metastases from colorectal cancer. Intraoperative blood loss, the need for blood transfusion, the complication rates, operating times, and the duration of postoperative h…

Malemedicine.medical_specialtyNecrosisBlood transfusionCarcinoma HepatocellularColorectal cancermedicine.medical_treatmentBlood Loss SurgicalHemoglobinsmedicineliver metastases cancer surgeryHepatectomyHumansAgedbusiness.industryLiver NeoplasmsGeneral MedicineLength of StayMiddle Agedmedicine.diseaseHemostasis SurgicalSurgerySettore MED/18 - Chirurgia GeneraleCoagulative necrosisHematocritHemostasisAnesthesiaHepatocellular carcinomaCatheter AblationFemalemedicine.symptomHepatectomyComplicationbusiness
researchProduct

Impact of perioperative transfusions and sepsis on long-term oncologic outcomes after curative colon cancer resection. A retrospective analysis of a …

2020

Objective: Intra-abdominal septic complications (IASC) affect short-term outcomes after surgery for colon cancer. Blood transfusions have been associated with worse short-term results.The role of IASC and blood transfusions on long-term oncologic results is still debated. This study aims to assess the impact of these two variables on survival after curative colon cancer resection. Patients and methods: Retrospective analysis of a prospectively maintained database of patients who underwent curative surgery for colon cancer at a university hospital, between 1993 and 2010. Cox regression was used to identify the role of IASC and transfusions (alone and combined) on local recurrence (LR), disea…

Malemedicine.medical_specialtyTime FactorsDatabases FactualSurvivalSepsiColorectal cancer030230 surgerycomputer.software_genre03 medical and health sciencesPostoperative Complications0302 clinical medicineSeptic complicationSepsisLocal recurrencemedicineHumansAnastomotic leakPerioperative PeriodAgedRetrospective StudiesAged 80 and overHepatologyDatabaseProportional hazards modelbusiness.industryMortality rateBlood transfusionHazard ratioGastroenterologyPerioperativeMiddle Agedmedicine.diseaseColorectal surgeryColon cancerSurvival RateBowel obstructionTreatment OutcomeAnastomotic leak Blood transfusion Colon cancer Complicaciones sépticas Complicación Complication Cáncer de colon Fuga anastomótica Local recurrence Recurrencia local Sepsis Septic complications Supervivencia Survival Transfusión de sangre030220 oncology & carcinogenesisColonic NeoplasmsFemaleComplicationbusinessComplicationcomputerSeptic complicationsGastroenterología y Hepatología
researchProduct